Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)

NCT00472901 · clinicaltrials.gov ↗

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Polymorphic Light Eruption (PLE)

Interventions

DRUG: Afamelanotide (CUV1647)

Sponsor

Clinuvel Pharmaceuticals Limited